Valeant in talks to sell eye surgical products business – Bbg


Canadian drugmaker Valeant
Pharmaceuticals International Inc is in talks
to sell its Bausch & Lomb unit’s surgical products business to
Germany’s Carl Zeiss Meditec AG, Bloomberg reported.


Valeant’s eye-surgery assets may be valued at about $2
billion in a sale, Bloomberg reported, citing people familiar
with the matter. (bloom.bg/2sckufc)

Valeant and Carl Zeiss were not immediately available for
comment.
(Reporting by Ahmed Farhatha in Bengaluru; Editing by Maju
Samuel)

‘);
$(‘.second-article-divide’).append($(‘.slider.slider-module’));
$(‘.third-article-divide’).append(‘

‘);
var median = (relatedItemsTotal / 2);
var $relatedContentGroupOne = $(‘.related-content.group-one ul’);
var $relatedContentGroupTwo = $(‘.related-content.group-two ul’);

$.each($relatedItems, function(k,v) {
if (k + 1